Project information
NISCI - Antibodies against Nogo-A to enhance plasticity, regeneration and functional recovery after acute spinal cord injury, a multicenter European randomized double blinded placebo controlled phase II clinical proof of concept trial (NISCI)

Investor logo
Project Identification
681094
Project Period
1/2016 - 6/2023
Investor / Pogramme / Project type
European Union
MU Faculty or unit
Faculty of Medicine
Cooperating Organization
University Hospital Prague - Motol
Ruhr-Universität Bochum
Universität Zürich
European Clinical Research Infrastructures Netwo
Heidelberg University Hospital

Antibodies against Nogo-A to enhance plasticity, regeneration and functional recovery after acute spinal cord injury, a multicenter European randomized double blinded placebo controlled phase II clinical proof of concept trial.

Sustainable Development Goals

Masaryk University is committed to the UN Sustainable Development Goals, which aim to improve the conditions and quality of life on our planet by 2030.

Sustainable Development Goal No.  3 – Good health and well-being Sustainable Development Goal No.  17 – Partnerships for the goals

Publications

Total number of publications: 2


You are running an old browser version. We recommend updating your browser to its latest version.

More info